Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- 4975 Rideau Street
- Industrial Park
- Quebec PQ, G2E 5H5
Feldan is engaged in the discovery, development, manufacturing and marketing of research & therapeutic protein products and services. The company markets products and services to the life science industry mainly in the US, Canada, and Europe; but also markets in other countries across the globe. Its innovation pipeline currently focuses on research areas that target treatment of serious illness in areas such as oncology, immunology, neuroscience, inflammation, and stem cell therapy.